M Quit 60mg Injection
Marketer
Quick Heal Life Sciences
Salt Composition
Artesunate (60mg)
Overview M Quit 60mg Injection
Malaria treatment with the 60mg M-Quit injection, an antiparasitic drug, is indicated for uncomplicated cases only. This injectable formulation is administered solely by medical professionals and is reserved for situations where oral medication is infeasible. It does not prevent malaria nor is it suitable for severe malaria involving neurological, pulmonary, or renal compromise. Common side effects can include headache, lightheadedness, fatigue, and decreased appetite. Local reactions at the injection site, such as soreness, inflammation, or erythema, may also occur. Persistent side effects necessitate medical consultation. Post-treatment, weekly blood tests to monitor parasite levels are typically recommended for four weeks.
Uses of M Quit 60mg Injection
Malarial infection
Major Benefits of M Quit 60mg Injection:
This medication will be administered by your healthcare provider; please do not attempt self-medication.
Common Side effects of M Quit 60mg Injection:
- Headache
- Dizziness
- Weakness
- Loss of appetite
- Injection site reactions (pain, swelling, redness)
How to use M Quit 60mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How M Quit 60mg Injection works:
M Quit 60mg Injection is an anti-malarial drug that eliminates the parasite by generating intracellular oxidative stress, leading to its demise.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside M Quit 60mg Injection may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of M Quit 60mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible hazards prior to prescribing. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use M Quit 60mg Injection without significant risk to their infants. Available human data indicates minimal danger to the baby.
DrivingUNSAFE
Administering M Quit 60mg Injection can lead to reduced awareness, visual impairment, drowsiness, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of M Quit 60mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of 60mg M Quit injections to individuals with hepatic impairment. Physician consultation is recommended.
What if you forget to take M Quit 60mg Injection :
Should you forget a scheduled dose of the M Quit 60mg Injection, seek advice from your physician.
Facts to Know About M Quit 60mg Injection
| Label | Value |
|---|---|
| Chemical Type | Sesquiterpene lactones |
| Developing Habits | No. |
| Type of Therapy | Antimalarial Medications |
| Behavioral Class | Artemisinin-based antimalarials |
3,018 People bought this recently